XML 28 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating Activities    
Net Income (Loss) $ 1,093,850 $ 259,688
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided (Used) by Operating Activities:    
Equity-Based and Other Non-Cash Compensation 183,411 184,135
Change in Unrealized (Gains) Losses - Asset Management and Strategic Holdings (829,067) 258,789
Net Accretion and Amortization (14,484) 32,180
Other Non-Cash Amounts 59,030 49,999
Cash Flows Due to Changes in Operating Assets and Liabilities:    
Change in Due from / to Affiliates (101,267) (145,301)
Change in Other Assets (19,836) 493,728
Change in Accrued Expenses and Other Liabilities 951,953 699,553
Net Cash Provided (Used) by Operating Activities 1,527,433 (1,932,888)
Investing Activities    
Purchases of Fixed Assets (17,295) (23,207)
Net Cash Provided (Used) by Investing Activities (6,198,779) (3,818,533)
Financing Activities    
Common Stock Dividends (146,026) (133,470)
Distributions to Redeemable Noncontrolling Interests (8,265) (636)
Contributions from Redeemable Noncontrolling Interests 282,253 0
Distributions to Noncontrolling Interests (1,732,066) (1,840,303)
Contributions from Noncontrolling Interests 1,434,323 2,468,778
2024 GA Acquisition - Cash consideration (See Note 1) (2,622,230) 0
Proceeds from Debt Obligations 5,717,282 3,378,792
Repayment of Debt Obligations (4,928,299) (1,858,984)
Net Cash Provided (Used) by Financing Activities 44,964 2,072,968
Effect of exchange rate changes on cash, cash equivalents and restricted cash (16,210) 21,603
Net Increase/(Decrease) in Cash, Cash Equivalents and Restricted Cash (4,642,592) (3,656,850)
Cash, Cash Equivalents and Restricted Cash, Beginning of Period 20,808,120 13,385,370
Cash, Cash Equivalents and Restricted Cash, End of Period 16,165,528 9,728,520
Cash, Cash Equivalents and Restricted Cash are comprised of the following:    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total 16,165,528 9,728,520
Supplemental Disclosures of Cash Flow Information    
Payments for Interest 745,412 566,904
Payments for Income Taxes 39,375 21,441
Payments for Operating Lease Liabilities 17,339 15,281
Supplemental Disclosures of Non-Cash Investing and Financing Activities    
Non-Cash Contribution from Noncontrolling Interests 3,879 0
Debt Obligations - Net Gains (Losses), Translation and Other 400,122 (428,559)
Right-of-Use Assets obtained in Exchange for new Operating Lease Liabilities 0 17,167
Investments Acquired through Reinsurance Agreements 9,996,537 0
Contractholder Deposit Funds Acquired through Reinsurance Agreements 1,229,728 24,083
Change in Consolidation    
Noncontrolling Interests 0 (93,545)
Series C Mandatory Convertible Preferred Stock Dividends    
Financing Activities    
Series C Mandatory Convertible Preferred Stock Dividends 0 (17,250)
Asset Management and Strategic Holdings    
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided (Used) by Operating Activities:    
Net Realized (Gains) Losses - Asset Management and Strategic Holdings 190,905 (99,380)
Change in Unrealized (Gains) Losses - Asset Management and Strategic Holdings (829,067) 258,789
Capital Allocation-Based (Income) Loss - Asset Management and Strategic Holdings (1,262,942) (449,018)
Cash Flows Due to Changes in Operating Assets and Liabilities:    
Investments Purchased - Asset Management and Strategic Holdings (10,454,480) (9,966,282)
Proceeds from Investments - Asset Management and Strategic Holdings 9,746,020 5,229,772
Financing Activities    
Cash, Cash Equivalents and Restricted Cash, Beginning of Period 8,510,491 6,958,756
Cash, Cash Equivalents and Restricted Cash, End of Period 7,311,417 5,737,740
Cash, Cash Equivalents and Restricted Cash are comprised of the following:    
Cash and Cash Equivalents 7,083,931 5,576,121
Restricted Cash and Cash Equivalents 227,486 161,619
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total 7,311,417 5,737,740
Insurance    
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided (Used) by Operating Activities:    
Net Investment and Policy Liability-Related (Gains) Losses - Insurance 591,288 953,155
Interest Credited to Policyholder Account Balances (net of Policy Fees) - Insurance 925,399 623,849
Cash Flows Due to Changes in Operating Assets and Liabilities:    
Reinsurance Transactions and Acquisitions, Net of Cash Provided - Insurance 152,861 242,554
Change in Premiums, Notes Receivable and Reinsurance Recoverable, Net of Reinsurance Premiums Payable - Insurance 583,293 (263,534)
Change in Deferred Policy Acquisition Costs - Insurance (178,684) (166,926)
Change in Policy Liabilities and Accruals, Net - Insurance (89,817) 130,151
Investing Activities    
Investments Purchased - Insurance (13,726,204) (8,769,518)
Proceeds from Investments - Insurance 7,528,657 4,956,273
Other Investing Activities, Net - Insurance 16,063 17,919
Financing Activities    
Additions to Contractholder Deposit Funds - Insurance 7,451,253 4,547,895
Withdrawals from Contractholder Deposit Funds - Insurance (4,887,018) (4,060,332)
Reinsurance Transactions, Net of Cash Provided - Insurance 12,198 79,516
Other Financing Activity, Net - Insurance (528,441) (491,038)
Cash, Cash Equivalents and Restricted Cash, Beginning of Period 12,297,629 6,426,614
Cash, Cash Equivalents and Restricted Cash, End of Period 8,854,111 3,990,780
Cash, Cash Equivalents and Restricted Cash are comprised of the following:    
Cash and Cash Equivalents 8,524,962 3,713,382
Restricted Cash and Cash Equivalents 329,149 277,398
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total 8,854,111 3,990,780
Change in Consolidation    
Investments - Insurance $ 0 $ (93,545)